Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol … C Ireson, S Orr, DJL Jones, R Verschoyle, CK Lim, JL Luo, L Howells, ... Cancer research 61 (3), 1058-1064, 2001 | 845 | 2001 |
Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine CR Ireson, DJL Jones, S Orr, MWH Coughtrie, DJ Boocock, ML Williams, ... Cancer Epidemiology Biomarkers & Prevention 11 (1), 105-111, 2002 | 812 | 2002 |
Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences G Garcea, DP Berry, DJL Jones, R Singh, AR Dennison, PB Farmer, ... Cancer Epidemiology Biomarkers & Prevention 14 (1), 120-125, 2005 | 654 | 2005 |
Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients KR Patel, VA Brown, DJL Jones, RG Britton, D Hemingway, AS Miller, ... Cancer research 70 (19), 7392-7399, 2010 | 637 | 2010 |
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration G Garcea, DJL Jones, R Singh, AR Dennison, PB Farmer, RA Sharma, ... British journal of cancer 90 (5), 1011-1015, 2004 | 558 | 2004 |
Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3, 4, 5, 4 … S Sale, RD Verschoyle, D Boocock, DJL Jones, N Wilsher, KC Ruparelia, ... British journal of cancer 90 (3), 736-744, 2004 | 300 | 2004 |
Trimethylamine N-oxide and prognosis in acute heart failure T Suzuki, LM Heaney, SS Bhandari, DJL Jones, LL Ng Heart 102 (11), 841-848, 2016 | 245 | 2016 |
Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction T Suzuki, LM Heaney, DJL Jones, LL Ng Clinical chemistry 63 (1), 420-428, 2017 | 148 | 2017 |
Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration—a clinical pilot study including assessment of patient acceptability GRB Irving, LM Howells, S Sale, I Kralj-Hans, WS Atkin, SK Clark, ... Cancer prevention research 6 (2), 119-128, 2013 | 128 | 2013 |
DNA adducts: mass spectrometry methods and future prospects PB Farmer, K Brown, E Tompkins, VL Emms, DJL Jones, R Singh, ... Toxicology and applied pharmacology 207 (2), 293-301, 2005 | 124 | 2005 |
DNA adducts: mass spectrometry methods and future prospects PB Farmer, K Brown, E Tompkins, VL Emms, DJL Jones, R Singh, ... Toxicology and applied pharmacology 207 (2), 293-301, 2005 | 119 | 2005 |
The human apoptosis-inducing protein AMID is an oxidoreductase with a modified flavin cofactor and DNA binding activity KR Marshall, M Gong, L Wodke, JH Lamb, DJL Jones, PB Farmer, ... Journal of Biological Chemistry 280 (35), 30735-30740, 2005 | 109 | 2005 |
Vitamin D and prognosis in acute myocardial infarction LL Ng, JK Sandhu, IB Squire, JE Davies, DJL Jones International journal of cardiology 168 (3), 2341-2346, 2013 | 106 | 2013 |
Curcumin ameliorates oxaliplatin‐induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo LM Howells, S Sale, SN Sriramareddy, GRB Irving, DJL Jones, CJ Ottley, ... International journal of cancer 129 (2), 476-486, 2011 | 105 | 2011 |
Association with outcomes and response to treatment of trimethylamine N‐oxide in heart failure: results from BIOSTAT‐CHF T Suzuki, Y Yazaki, AA Voors, DJL Jones, DCS Chan, SD Anker, ... European journal of heart failure 21 (7), 877-886, 2019 | 84 | 2019 |
Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure: a GREAT network study LL Ng, IB Squire, DJL Jones, TH Cao, DCS Chan, JK Sandhu, PA Quinn, ... Journal of the American college of cardiology 69 (1), 56-69, 2017 | 82 | 2017 |
Proenkephalin and prognosis after acute myocardial infarction LL Ng, JK Sandhu, H Narayan, PA Quinn, IB Squire, JE Davies, ... Journal of the American College of Cardiology 63 (3), 280-289, 2014 | 79 | 2014 |
Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma CD Mann, C Bastianpillai, CP Neal, MM Masood, DJL Jones, F Teichert, ... PloS one 7 (12), e51119, 2012 | 71 | 2012 |
A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer I Garrido-Laguna, KA McGregor, M Wade, J Weis, W Gilcrease, L Burr, ... Investigational new drugs 31, 1257-1264, 2013 | 66 | 2013 |
Determination of quercetin in human plasma by HPLC with spectrophotometric or electrochemical detection DJL Jones, CK Lim, DR Ferry, A Gescher Biomedical Chromatography 12 (4), 232-235, 1998 | 66 | 1998 |